Harrow Inc

Opaleye’s sharp insider sell‑off of 140k Harrow shares amid a bearish market may signal short‑term pain, but the company’s upcoming trial results could tilt the narrative toward growth. Explore the details.

Opaleye Management’s recent Harrow sell signals a tactical pullback amid market volatility—insider moves hint at cautious profit‑taking, not a loss of faith.